Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-07-096263
Filing Date
2007-04-30
Accepted
2007-04-30 17:19:16
Documents
3
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FROM 10-K d10ka.htm 10-K/A 285484
2 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex313.htm EX-31.3 2374
3 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex314.htm EX-31.4 2392
  Complete submission text file 0001193125-07-096263.txt   291772
Mailing Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650.635.1100
Monogram Biosciences, Inc. (Filer) CIK: 0001094961 (see all company filings)

EIN.: 943234479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-30369 | Film No.: 07801865
SIC: 2835 In Vitro & In Vivo Diagnostic Substances